- Home
- EVOK vs TRIB Comparison
EVOK vs TRIB Comparison
Compare EVOK & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVOK
- TRIB
- Stock Information
- Founded
- EVOK 2007
- TRIB 1992
- Country
- EVOK United States
- TRIB Ireland
- Employees
- EVOK 3
- TRIB N/A
- Industry
- EVOK Biotechnology: Pharmaceutical Preparations
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- EVOK Health Care
- TRIB Health Care
- Exchange
- EVOK Nasdaq
- TRIB Nasdaq
- Market Cap
- EVOK 7.6M
- TRIB 5.4M
- IPO Year
- EVOK 2013
- TRIB N/A
- Fundamental
- Price
- EVOK $4.90
- TRIB $0.98
- Analyst Decision
- EVOK
- TRIB
- Analyst Count
- EVOK 0
- TRIB 0
- Target Price
- EVOK N/A
- TRIB N/A
- AVG Volume (30 Days)
- EVOK 27.4K
- TRIB 120.8K
- Earning Date
- EVOK 11-07-2025
- TRIB 11-14-2025
- Dividend Yield
- EVOK N/A
- TRIB N/A
- EPS Growth
- EVOK N/A
- TRIB N/A
- EPS
- EVOK N/A
- TRIB N/A
- Revenue
- EVOK $12,794,859.00
- TRIB $61,555,000.00
- Revenue This Year
- EVOK $57.38
- TRIB $13.51
- Revenue Next Year
- EVOK $59.57
- TRIB $13.14
- P/E Ratio
- EVOK N/A
- TRIB N/A
- Revenue Growth
- EVOK 70.02
- TRIB 8.31
- 52 Week Low
- EVOK $1.94
- TRIB $0.48
- 52 Week High
- EVOK $12.32
- TRIB $3.44
- Technical
- Relative Strength Index (RSI)
- EVOK 52.02
- TRIB 43.05
- Support Level
- EVOK $4.53
- TRIB $0.88
- Resistance Level
- EVOK $4.69
- TRIB $1.10
- Average True Range (ATR)
- EVOK 0.27
- TRIB 0.07
- MACD
- EVOK 0.06
- TRIB 0.00
- Stochastic Oscillator
- EVOK 61.43
- TRIB 42.19
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.